Moderna Inc (MRNA)
38.28
+1.34
(+3.63%)
USD |
NASDAQ |
Nov 21, 13:10
Moderna Market Cap: 14.73B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 14.22B |
| November 19, 2024 | 14.35B |
| November 18, 2024 | 15.20B |
| November 15, 2024 | 14.18B |
| November 14, 2024 | 15.30B |
| November 13, 2024 | 16.22B |
| November 12, 2024 | 16.73B |
| November 11, 2024 | 16.45B |
| November 08, 2024 | 18.02B |
| November 07, 2024 | 19.35B |
| November 06, 2024 | 19.94B |
| November 05, 2024 | 20.51B |
| November 04, 2024 | 20.60B |
| November 01, 2024 | 21.02B |
| October 31, 2024 | 20.92B |
| October 30, 2024 | 21.07B |
| October 29, 2024 | 21.26B |
| October 28, 2024 | 21.10B |
| October 25, 2024 | 20.44B |
| October 24, 2024 | 20.33B |
| October 23, 2024 | 20.56B |
| October 22, 2024 | 20.56B |
| October 21, 2024 | 20.71B |
| October 18, 2024 | 20.83B |
| October 17, 2024 | 21.11B |
| Date | Value |
|---|---|
| October 16, 2024 | 22.12B |
| October 15, 2024 | 22.06B |
| October 14, 2024 | 22.23B |
| October 11, 2024 | 22.44B |
| October 10, 2024 | 21.88B |
| October 09, 2024 | 22.66B |
| October 08, 2024 | 22.48B |
| October 07, 2024 | 22.61B |
| October 04, 2024 | 23.18B |
| October 03, 2024 | 23.51B |
| October 02, 2024 | 24.32B |
| October 01, 2024 | 24.61B |
| September 30, 2024 | 25.73B |
| September 27, 2024 | 25.27B |
| September 26, 2024 | 24.57B |
| September 25, 2024 | 24.46B |
| September 24, 2024 | 24.58B |
| September 23, 2024 | 24.66B |
| September 20, 2024 | 25.25B |
| September 19, 2024 | 26.15B |
| September 18, 2024 | 26.85B |
| September 17, 2024 | 27.67B |
| September 16, 2024 | 26.59B |
| September 13, 2024 | 26.25B |
| September 12, 2024 | 26.78B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.984B
Minimum
Jan 07 2020
195.55B
Maximum
Aug 09 2021
53.35B
Average
48.63B
Median
Sep 22 2022
Market Cap Benchmarks
| Eli Lilly and Co | 711.43B |
| Merck & Co Inc | 251.45B |
| Pfizer Inc | 142.24B |
| Novavax Inc | 1.317B |
| Vertex Pharmaceuticals Inc | 116.31B |
Market Cap Related Metrics
| PS Ratio | 2.928 |
| Price to Book Value | 1.235 |
| Price | 38.28 |
| Earnings Yield | -15.20% |